GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medical Data Vision Co Ltd (TSE:3902) » Definitions » Operating Income

Medical Data Vision Co (TSE:3902) Operating Income : 円1,401 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Medical Data Vision Co Operating Income?

Medical Data Vision Co's Operating Income for the three months ended in Mar. 2024 was 円54 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was 円1,401 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Medical Data Vision Co's Operating Income for the three months ended in Mar. 2024 was 円54 Mil. Medical Data Vision Co's Revenue for the three months ended in Mar. 2024 was 円1,389 Mil. Therefore, Medical Data Vision Co's Operating Margin % for the quarter that ended in Mar. 2024 was 3.86%.

Good Sign:

Medical Data Vision Co Ltd operating margin is expanding. Margin expansion is usually a good sign.

Medical Data Vision Co's 5-Year average Growth Rate for Operating Margin % was 19.90% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medical Data Vision Co's annualized ROC % for the quarter that ended in Mar. 2024 was -5.76%. Medical Data Vision Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 102.47%.


Medical Data Vision Co Operating Income Historical Data

The historical data trend for Medical Data Vision Co's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Data Vision Co Operating Income Chart

Medical Data Vision Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 809.61 1,146.40 1,594.22 1,758.05 1,770.92

Medical Data Vision Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 423.66 295.91 391.70 659.65 53.65

Medical Data Vision Co Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,401 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medical Data Vision Co  (TSE:3902) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medical Data Vision Co's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=214.616 * ( 1 - 176.04% )/( (2745.709 + 2924.425)/ 2 )
=-163.1940064/2835.067
=-5.76 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6221.216 - 618.799 - ( 3218.073 - max(0, 1805.513 - 4662.221+3218.073))
=2745.709

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=5632.444 - 172.435 - ( 2854.084 - max(0, 1473.511 - 4009.095+2854.084))
=2924.425

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Medical Data Vision Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=214.616/( ( (158.52 + max(-377.643, 0)) + (260.371 + max(-318.5, 0)) )/ 2 )
=214.616/( ( 158.52 + 260.371 )/ 2 )
=214.616/209.4455
=102.47 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1107.764 + 6.082 + 314.024) - (618.799 + 0 + 1186.714)
=-377.643

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(822.348 + 4.849 + 327.814) - (172.435 + 0 + 1301.076)
=-318.5

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Medical Data Vision Co's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=53.654/1388.565
=3.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Medical Data Vision Co Operating Income Related Terms

Thank you for viewing the detailed overview of Medical Data Vision Co's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Medical Data Vision Co (TSE:3902) Business Description

Traded in Other Exchanges
N/A
Address
7, Kandamitoshirocho, Chiyoda-ku, Tokyo, JPN, 101-0053
Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.

Medical Data Vision Co (TSE:3902) Headlines

No Headlines